Earnings Conference Call to be held on April 3, 2007 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong)
SHENYANG, China, March 22 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it will release unaudited financial results for the fourth quarter and fiscal year ended December 31, 2006 after the US market closes on Monday, April 2, 2007.
The earnings release will be available on the investor relations page of its website at http://www.3sbio.com .
Following the earnings announcement, 3SBio senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on Tuesday, April 3, 2007 to discuss its fourth quarter and fiscal year 2007 financial results and recent business activity. The conference call may be accessed by calling (US) +1 480 629 9564 / (UK) +44 (0)20 8515 2301 / (HK) +852 3009 5027. A telephone replay will be available shortly after the call until April 16, 2007 at (US) +1 303 590 3030 / (UK) +44 (0)20 7154 2833, Passcode: 3714705; and (HK) +852 2287 4304, Passcode: 095110#.
A live webcast of the conference call and replay will be available on the investor relations page of 3SBio’s website at http://www.3sbio.com .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .
For more information, please contact:
Investor Contact:
Clara Mak, CFO
3SBio Inc.
Tel: +86-24-2581-1820
Investor Relations(HK):
Ruby Yim
Taylor Rafferty
Tel: +852-3196-3712
Investor Relations(US):
Mahmoud Siddig
Taylor Rafferty
Tel: +1-212-889-4350
Media Contact:
John Dooley
Taylor Rafferty
Tel: +1-212-889-4350
